Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Duration of outpatient fecal colonization due to Escherichia coli Isolates with decreased susceptibility to fluoroquinolones: longitudinal study of patients recently discharged from the hospital.

Literature DB >> 16982789

Duration of outpatient fecal colonization due to Escherichia coli Isolates with decreased susceptibility to fluoroquinolones: longitudinal study of patients recently discharged from the hospital.

Ebbing Lautenbach¹, Pam Tolomeo, Xiangqun Mao, Neil O Fishman, Joshua P Metlay, Warren B Bilker, Irving Nachamkin.

Abstract

Among 10 subjects colonized with Escherichia coli isolates with reduced susceptibility to fluoroquinolones, the median duration of colonization following hospital discharge was 80 days (range, 8 to 172 days). Colonization was longer for isolates demonstrating organic-solvent tolerance than for isolates that were not organic-solvent tolerant (151 versus 29 days, respectively; P = 0.07) but was not associated with other resistance mechanisms, demographics, or antibiotic use.

Entities: Chemical Species

Mesh：

Substances：

Year: 2006 PMID： 16982789 PMCID： PMC1635175 DOI： 10.1128/AAC.00503-06

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

12 in total

Review 1. Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance.

Authors: José L Martínez; Fernando Baquero
Journal: Clin Microbiol Rev Date: 2002-10 Impact factor: 26.132

2. Test characteristics of perirectal and rectal swab compared to stool sample for detection of fluoroquinolone-resistant Escherichia coli in the gastrointestinal tract.

Authors: Ebbing Lautenbach; Anthony D Harris; Eli N Perencevich; Irving Nachamkin; Pam Tolomeo; Joshua P Metlay
Journal: Antimicrob Agents Chemother Date: 2005-02 Impact factor: 5.191

3. Molecular epidemiology and evolution of resistance to quinolones in Escherichia coli after prolonged administration of ciprofloxacin in patients with prostatitis.

Authors: Juan P Horcajada; Jordi Vila; Antonio Moreno-Martínez; Joaquim Ruiz; Jose Antonio Martínez; Miquel Sánchez; Eladio Soriano; Josep Mensa
Journal: J Antimicrob Chemother Date: 2002-01 Impact factor: 5.790

4. Incidence and clinical impact of fluoroquinolone-resistant Escherichia coli in the faecal flora of cancer patients treated with high dose chemotherapy and ciprofloxacin prophylaxis.

Authors: S Perea; M Hidalgo; A Arcediano; M J Ramos; C Gomez; J Hornedo; C Lumbreras; D Folgueira; H Cortes-Funes; A Rodriguez-Noriega
Journal: J Antimicrob Chemother Date: 1999-07 Impact factor: 5.790

5. Colonization and infection with fluoroquinolone-resistant Escherichia coli among cancer patients: clonal analysis.

Authors: M Oethinger; A S Jellen-Ritter; S Conrad; R Marre; W V Kern
Journal: Infection Date: 1998 Nov-Dec Impact factor: 3.553

6. Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations.

Authors: H Wang; J L Dzink-Fox; M Chen; S B Levy
Journal: Antimicrob Agents Chemother Date: 2001-05 Impact factor: 5.191

7. Active efflux of bile salts by Escherichia coli.

Authors: D G Thanassi; L W Cheng; H Nikaido
Journal: J Bacteriol Date: 1997-04 Impact factor: 3.490

8. Phenotypic and genotypic characterization of fecal Escherichia coli isolates with decreased susceptibility to fluoroquinolones: results from a large hospital-based surveillance initiative.

Authors: Ebbing Lautenbach; Neil O Fishman; Joshua P Metlay; Xiangqun Mao; Warren B Bilker; Pam Tolomeo; Irving Nachamkin
Journal: J Infect Dis Date: 2006-05-31 Impact factor: 5.226

9. Natural history of colonization with vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and resistant gram-negative bacilli among long-term-care facility residents.

Authors: Glenn A Pacio; Paul Visintainer; George Maguire; Gary P Wormser; John Raffalli; Marisa A Montecalvo
Journal: Infect Control Hosp Epidemiol Date: 2003-04 Impact factor: 3.254

10. Prevalence of plasmid-mediated quinolone resistance.

Authors: George A Jacoby; Nancy Chow; Ken B Waites
Journal: Antimicrob Agents Chemother Date: 2003-02 Impact factor: 5.191

8 in total

1. Genomic comparison of multi-drug resistant invasive and colonizing Acinetobacter baumannii isolated from diverse human body sites reveals genomic plasticity.

Authors: Jason W Sahl; J Kristie Johnson; Anthony D Harris; Adam M Phillippy; William W Hsiao; Kerri A Thom; David A Rasko
Journal: BMC Genomics Date: 2011-06-04 Impact factor: 3.969

2. Prolonged carriage of resistant E. coli by returned travellers: clonality, risk factors and bacterial characteristics.

Authors: B A Rogers; K J Kennedy; H E Sidjabat; M Jones; P Collignon; D L Paterson
Journal: Eur J Clin Microbiol Infect Dis Date: 2012-03-07 Impact factor: 3.267

3. Temporal changes in resistance mechanisms in colonizing Escherichia coli isolates with reduced susceptibility to fluoroquinolones.

Authors: Jennifer H Han; Irving Nachamkin; Pam Tolomeo; Xiangqun Mao; Warren B Bilker; Ebbing Lautenbach
Journal: Diagn Microbiol Infect Dis Date: 2013-05-27 Impact factor: 2.803

4. SHEA/APIC guideline: infection prevention and control in the long-term care facility, July 2008.

Authors: Philip W Smith; Gail Bennett; Suzanne Bradley; Paul Drinka; Ebbing Lautenbach; James Marx; Lona Mody; Lindsay Nicolle; Kurt Stevenson
Journal: Infect Control Hosp Epidemiol Date: 2008-09 Impact factor: 3.254

5. The Perfect Condition for the Rising of Superbugs: Person-to-Person Contact and Antibiotic Use Are the Key Factors Responsible for the Positive Correlation between Antibiotic Resistance Gene Diversity and Virulence Gene Diversity in Human Metagenomes.

Authors: Célia P F Domingues; João S Rebelo; Joël Pothier; Francisca Monteiro; Teresa Nogueira; Francisco Dionisio
Journal: Antibiotics (Basel) Date: 2021-05-20